The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)

Background. Thyroid disease is one of the most common pathologies in the world, wich includs hypothyroidism, hyperthyroidism and thyroid cancer. At the present, there is an increase in their cases. The thyroid gland is an extremely important for the health of a person, thyroid hormones are necessary...

Full description

Bibliographic Details
Main Author: Н. С. Підченко
Format: Article
Language:English
Published: National Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and Oncology 2020-12-01
Series:Український радіологічний та онкологічний журнал
Subjects:
Online Access:https://ukroj.com/index.php/journal/article/view/57
_version_ 1823930604938330112
author Н. С. Підченко
author_facet Н. С. Підченко
author_sort Н. С. Підченко
collection DOAJ
description Background. Thyroid disease is one of the most common pathologies in the world, wich includs hypothyroidism, hyperthyroidism and thyroid cancer. At the present, there is an increase in their cases. The thyroid gland is an extremely important for the health of a person, thyroid hormones are necessary for the normal functioning of all tissues in the body. Purpose. To structure and summarize scientific findings on the role of thyroid hormones (T4, T3 and rT3) in the development of hypothyroidism, their effect on inhibiting the growth of cancer cells and the cytotoxic effects of these hormones on thyroid cells. Results and discussion. In spite of a careful study of thyroid function, the use of thyroid hormones and laboratory monitoring in the treatment of various thyroid pathologies remains debatable up to now. In particular, it concerns LT4 + LT3 combination and the role of reversible T3. This is due to a complex regulation system depending on many factors: hormonal homeostasis, nutritional factors, physiological conditions, etc., which together maintain appropriate thyroid functioning. LT4 monotherapy remains the standard method of replacement therapy, however, according to the ETA recommendations, it is possible for individual patients to prescribe combination therapy LT4 + LT3 as an experimental approach. The use of the rT3 test as a prognostic / diagnostic indicator for monitoring the therapy of patients receiving L-thyroxine therapy is discussed. The use of L-thyroxine as a thyrotropic suppressive therapy in the treatment of thyroid cancer requires careful dose adjustment depending on the health status of each patient, the risk of recurrence, which requires monitoring and dynamic reassessment. Long-term suppressive therapy of LT4 can affect metabolism, contributing to weight loss. Conclusions. Given the analysis of the literature, which covered 20 years, today L-T4 monotherapy is the standard therapy for patients with hypothyroidism. LT4 + LT3 combination therapy can be recommended in patients receiving L-T4 treatment with complaints characteristic of hypothyroidism despite normal TSH levels, with the exception of other chronic and concomitant autoimmune diseases that may be the cause.
first_indexed 2024-12-16T21:26:53Z
format Article
id doaj.art-7ee9c78c27494200afb3c6aae876ca60
institution Directory Open Access Journal
issn 2708-7166
2708-7174
language English
last_indexed 2024-12-16T21:26:53Z
publishDate 2020-12-01
publisher National Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and Oncology
record_format Article
series Український радіологічний та онкологічний журнал
spelling doaj.art-7ee9c78c27494200afb3c6aae876ca602022-12-21T22:15:42ZengNational Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and OncologyУкраїнський радіологічний та онкологічний журнал2708-71662708-71742020-12-0128438740210.46879/ukroj.4.2020.387-40257The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)Н. С. Підченко0State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine», Kharkiv, UkraineBackground. Thyroid disease is one of the most common pathologies in the world, wich includs hypothyroidism, hyperthyroidism and thyroid cancer. At the present, there is an increase in their cases. The thyroid gland is an extremely important for the health of a person, thyroid hormones are necessary for the normal functioning of all tissues in the body. Purpose. To structure and summarize scientific findings on the role of thyroid hormones (T4, T3 and rT3) in the development of hypothyroidism, their effect on inhibiting the growth of cancer cells and the cytotoxic effects of these hormones on thyroid cells. Results and discussion. In spite of a careful study of thyroid function, the use of thyroid hormones and laboratory monitoring in the treatment of various thyroid pathologies remains debatable up to now. In particular, it concerns LT4 + LT3 combination and the role of reversible T3. This is due to a complex regulation system depending on many factors: hormonal homeostasis, nutritional factors, physiological conditions, etc., which together maintain appropriate thyroid functioning. LT4 monotherapy remains the standard method of replacement therapy, however, according to the ETA recommendations, it is possible for individual patients to prescribe combination therapy LT4 + LT3 as an experimental approach. The use of the rT3 test as a prognostic / diagnostic indicator for monitoring the therapy of patients receiving L-thyroxine therapy is discussed. The use of L-thyroxine as a thyrotropic suppressive therapy in the treatment of thyroid cancer requires careful dose adjustment depending on the health status of each patient, the risk of recurrence, which requires monitoring and dynamic reassessment. Long-term suppressive therapy of LT4 can affect metabolism, contributing to weight loss. Conclusions. Given the analysis of the literature, which covered 20 years, today L-T4 monotherapy is the standard therapy for patients with hypothyroidism. LT4 + LT3 combination therapy can be recommended in patients receiving L-T4 treatment with complaints characteristic of hypothyroidism despite normal TSH levels, with the exception of other chronic and concomitant autoimmune diseases that may be the cause.https://ukroj.com/index.php/journal/article/view/57thyroid gland, thyroid cancer, thyroid hormones, thyroxine, triiodothyronine, reversible triiodothyronine, l-thyroxine.
spellingShingle Н. С. Підченко
The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)
Український радіологічний та онкологічний журнал
thyroid gland, thyroid cancer, thyroid hormones, thyroxine, triiodothyronine, reversible triiodothyronine, l-thyroxine.
title The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)
title_full The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)
title_fullStr The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)
title_full_unstemmed The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)
title_short The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review)
title_sort use of l thyroxine in the treatment of thyroid pathologies and problems of therapy control literature review
topic thyroid gland, thyroid cancer, thyroid hormones, thyroxine, triiodothyronine, reversible triiodothyronine, l-thyroxine.
url https://ukroj.com/index.php/journal/article/view/57
work_keys_str_mv AT nspídčenko theuseoflthyroxineinthetreatmentofthyroidpathologiesandproblemsoftherapycontrolliteraturereview
AT nspídčenko useoflthyroxineinthetreatmentofthyroidpathologiesandproblemsoftherapycontrolliteraturereview